KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 120 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $152,000 | -94.5% | 26,000 | -95.0% | 0.00% | -93.8% |
| Q3 2016 | $2,741,000 | -1.7% | 516,110 | +22.6% | 0.05% | -9.4% |
| Q2 2016 | $2,788,000 | +41.7% | 421,110 | 0.0% | 0.05% | +39.5% |
| Q1 2016 | $1,967,000 | -7.5% | 421,110 | 0.0% | 0.04% | +2.7% |
| Q4 2015 | $2,127,000 | +43.5% | 421,110 | 0.0% | 0.04% | +48.0% |
| Q3 2015 | $1,482,000 | -82.3% | 421,110 | -49.9% | 0.02% | -58.3% |
| Q2 2015 | $8,384,000 | -27.6% | 840,000 | -7.7% | 0.06% | -63.6% |
| Q1 2015 | $11,588,000 | +1.7% | 910,302 | +13.0% | 0.16% | -1.8% |
| Q4 2014 | $11,398,000 | -32.2% | 805,502 | -35.0% | 0.17% | -32.0% |
| Q3 2014 | $16,799,000 | – | 1,239,806 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |